PALO ALTO, Calif., June 7, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be hosting its second FlashForward™ Consortium meeting at 12:00pm Tuesday, June 11th at the 58th annual Particle Therapy Co-Operative Group meeting (PTCOG) in Manchester, United Kingdom. The FlashForward Consortium's mission is to continue research and build an evidence-based introduction of FLASH Therapy using the ProBeam® platform.
In addition to the FlashForward Consortium meeting, Varian will be hosting a lunch symposium, one oral presentation and two ePosters on FLASH Therapy at PTCOG58:
Varian Lunch Symposium:
Ad Statistics
Times Displayed: 22281
Times Visited: 445 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
"FLASH Therapy: A Potential Paradigm Shift in Cancer Treatment"
Thursday, June 13th from 12:15 – 1:15
Manchester Central, Exchange Auditorium
Oral Presentation:
Planning and Delivery of FLASH in a clinical ProBeam: a preclinical study: by Eric Abel on Saturday, June 15th, 10:30am-12:00pm at the Exchange Auditorium
ePosters:
FLASH Radiotherapy: A look at ultra-high dose rate research and treatment plans: by Anthony Magliari and Jessica Perez
Proton beam diagnostics for ultra-high dose rate irradiations: by Simon Busold and Juergen Heese
FLASH Therapy is a non-invasive treatment using an external beam delivered in high doses, at ultra-high speeds (less than 1 second), and in one to three treatments. It represents an exciting and potentially promising new direction in the treatment of cancer.
About Varian
Varian is a leader in developing and delivering cancer care solutions and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 7,000 people around the world. For more information, visit www.varian.com and follow @VarianMedSys on Twitter.
